Covered recipient · General Payments record
NICOLE M DAVIA
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$1,121.70
- Reported across 36 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $484.10 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $123.37 | 1 |
| E.R. Squibb & Sons, L.L.C. | $120.86 | 3 |
| Merck Sharp & Dohme Corporation | $86.20 | 1 |
| PFIZER INC. | $73.48 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $22.46 | 1 |
| Tempus AI, Inc | $20.13 | 1 |
| Janssen Biotech, Inc. | $19.42 | 1 |
| Amgen Inc. | $18.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $18.18 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117536676 | CMS |
| E.R. Squibb & Sons, L.L.C. | $78.89 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101555628 | CMS |
| E.R. Squibb & Sons, L.L.C. | $20.55 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101555682 | CMS |
| E.R. Squibb & Sons, L.L.C. | $21.42 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101555698 | CMS |
| Janssen Biotech, Inc. | $19.42 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078330008 | CMS |
| Lilly USA, LLC | $123.37 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135907260 | CMS |
| Merck Sharp & Dohme LLC | $86.20 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141635153 | CMS |
| Novartis Pharmaceuticals Corporation | $22.46 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086945895 | CMS |
| PFIZER INC. | $73.48 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131438622 | CMS |
| Tempus AI, Inc | $20.13 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150180087 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.